Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report

BACKGROUND: The discovery of epidermal growth factor receptor oncogenic driver mutations has changed the therapeutic landscape of advanced non-small cell lung cancer in the past decade. Since the introduction of next-generation sequencing, uncommon epidermal growth factor receptor mutations are more...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Acker, Lander, Stevens, Dieter, Vermaelen, Karim, Surmont, Veerle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609878/
https://www.ncbi.nlm.nih.gov/pubmed/34809713
http://dx.doi.org/10.1186/s13256-021-02994-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609878/
https://www.ncbi.nlm.nih.gov/pubmed/34809713
http://dx.doi.org/10.1186/s13256-021-02994-0

Ejemplares similares